United Kingdom - English - myHealthbox

omega pharma ltd - nicotine - transdermal patch. - 36 mg/ 7 cm2 - anti-smoking agents - niquitin clear relieves and/or prevents craving and nicotine withdrawal symptoms associated with tobacco dependence. it is indicated to aid smokers wishing to quit or reduce prior to quitting, to assist smokers who are unwilling or unable to smoke, and as a safer alternative to smoking for smokers and those around them. niquitin clear is indicated in pregnant and lactating women making a quit attempt. if possible, when stopping smoking, niquitin clear should be used in conjunction with a behavioural support programme.

United Kingdom - English - myHealthbox

omega pharma ltd - nicotine - transdermal patch. - 114 mg/22 cm2 - anti-smoking agents - niquitin clear relieves and/or prevents craving and nicotine withdrawal symptoms associated with tobacco dependence. it is indicated to aid smokers wishing to quit or reduce prior to quitting, to assist smokers who are unwilling or unable to smoke, and as a safer alternative to smoking for smokers and those around them. niquitin clear is indicated in pregnant and lactating women making a quit attempt. if possible, when stopping smoking, niquitin clear should be used in conjunction with a behavioural support programme.

United Kingdom - English - myHealthbox

lupin (europe) limited - celecoxib - capsule, hard - 100mg - non-steroidal antiinflammatory and antirheumatic drugs, nsaids, coxibs - symptomatic relief in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis in adults. the decision to prescribe a selective cox-2 inhibitor should be based on an assessment of the individual patient's overall risks

United Kingdom - English - myHealthbox

lupin (europe) limited - celecoxib - capsule, hard - 200mg - non-steroidal antiinflammatory and antirheumatic drugs, nsaids, coxibs. - symptomatic relief in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis in adults. the decision to prescribe a selective cox-2 inhibitor should be based on an assessment of the individual patient's overall risks

United Kingdom - English - VMD (Veterinary Medicines Directorate)

norbrook laboratories limited - propofol - emulsion for injection - neurological agent general anaesthetic - cats, dogs

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - sevoflurane - anesthetics, general - dogs; cats - for the induction and maintenance of anaesthesia in dogs and cats.

European Union - English - EMA (European Medicines Agency)

chanelle pharmaceuticals manufacturing limited - sevoflurane - anesthetics, general - dogs; cats - for the induction and maintenance of anaesthesia.

Ireland - English - HPRA (Health Products Regulatory Authority)

norbrook laboratories limited - propofol - emulsion for injection - 10 milligram(s)/millilitre - propofol - cats, dogs - anaesthetic/analgesic

Canada - English - Health Canada

pharmascience inc - glyburide - tablet - 5mg - glyburide 5mg - sulfonylureas

Canada - English - Health Canada

zoetis canada inc - bacitracin (bacitracin methylene disalicylate) - drug premix - 110g - bacitracin (bacitracin methylene disalicylate) 110g - swine (pigs); poultry; poultry